206 related articles for article (PubMed ID: 37759471)
21. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status.
Murphy LC; Lee-Wing M; Goldenberg GJ; Shiu RP
Cancer Res; 1987 Aug; 47(15):4160-4. PubMed ID: 3607757
[TBL] [Abstract][Full Text] [Related]
22. Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D.
Murphy LC; Tsuyuki D; Myal Y; Shiu RP
J Biol Chem; 1987 Nov; 262(31):15236-41. PubMed ID: 3667631
[TBL] [Abstract][Full Text] [Related]
23. The prolactin inducible protein/gross cystic disease fluid protein-15 deficient mice develop anomalies in lymphoid organs.
Edechi CA; Nasr MR; Karim A; Blanchard AA; Ellison CA; Qui H; Uzonna JE; Myal Y
Immunobiology; 2019 Nov; 224(6):811-816. PubMed ID: 31447246
[TBL] [Abstract][Full Text] [Related]
24. Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation.
Baniwal SK; Little GH; Chimge NO; Frenkel B
J Cell Physiol; 2012 May; 227(5):2276-82. PubMed ID: 21809344
[TBL] [Abstract][Full Text] [Related]
25. Prolactin-induced protein in breast cancer.
Naderi A
Adv Exp Med Biol; 2015; 846():189-200. PubMed ID: 25472539
[TBL] [Abstract][Full Text] [Related]
26. Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner.
Baniwal SK; Chimge NO; Jordan VC; Tripathy D; Frenkel B
PLoS One; 2014; 8(6):e62361. PubMed ID: 23755096
[TBL] [Abstract][Full Text] [Related]
27. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
28. Prolactin-Inducible Protein: From Breast Cancer Biomarker to Immune Modulator-Novel Insights from Knockout Mice.
Ihedioha OC; Shiu RP; Uzonna JE; Myal Y
DNA Cell Biol; 2016 Oct; 35(10):537-541. PubMed ID: 27602994
[TBL] [Abstract][Full Text] [Related]
29. A functional and regulatory network associated with PIP expression in human breast cancer.
Debily MA; Marhomy SE; Boulanger V; Eveno E; Mariage-Samson R; Camarca A; Auffray C; Piatier-Tonneau D; Imbeaud S
PLoS One; 2009; 4(3):e4696. PubMed ID: 19262752
[TBL] [Abstract][Full Text] [Related]
30. Prolactin inducible protein in cancer, fertility and immunoregulation: structure, function and its clinical implications.
Hassan MI; Waheed A; Yadav S; Singh TP; Ahmad F
Cell Mol Life Sci; 2009 Feb; 66(3):447-59. PubMed ID: 18854942
[TBL] [Abstract][Full Text] [Related]
31. The human breast cancer-associated protein, the prolactin-inducible protein (PIP), regulates intracellular signaling events and cytokine production by macrophages.
Ihedioha O; Blanchard AA; Balhara J; Okwor I; Jia P; Uzonna J; Myal Y
Immunol Res; 2018 Apr; 66(2):245-254. PubMed ID: 29536339
[TBL] [Abstract][Full Text] [Related]
32. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells.
Autiero M; Cammarota G; Friedlein A; Zulauf M; Chiappetta G; Dragone V; Guardiola J
Eur J Immunol; 1995 May; 25(5):1461-4. PubMed ID: 7774651
[TBL] [Abstract][Full Text] [Related]
33. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.
Clark JW; Snell L; Shiu RP; Orr FW; Maitre N; Vary CP; Cole DJ; Watson PH
Br J Cancer; 1999 Nov; 81(6):1002-8. PubMed ID: 10576657
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of prolactin receptor expression in breast cancer subtypes].
Kalinina TS; Kononchuk VV; Sidorov SV; Gulyaeva LF
Biomed Khim; 2020 Jan; 66(1):89-94. PubMed ID: 32116231
[TBL] [Abstract][Full Text] [Related]
35. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
36. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
[TBL] [Abstract][Full Text] [Related]
37. Prolactin Inducible Protein, but Not Prolactin, Is Present in Human Tears, Is Involved in Tear Film Quality, and Influences Evaporative Dry Eye Disease.
Jüngert K; Paulsen F; Jacobi C; Horwath-Winter J; Garreis F
Front Med (Lausanne); 2022; 9():892831. PubMed ID: 35847789
[TBL] [Abstract][Full Text] [Related]
38. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
[TBL] [Abstract][Full Text] [Related]
39. Generation of prolactin-inducible protein (Pip) knockout mice by CRISPR/Cas9-mediated gene engineering.
Terceiro LEL; Blanchard AAA; Edechi CA; Freznosa A; Triggs-Raine B; Leygue E; Myal Y
Can J Physiol Pharmacol; 2022 Jan; 100(1):86-91. PubMed ID: 34379992
[TBL] [Abstract][Full Text] [Related]
40. Expression of gross cystic disease fluid protein-15/Prolactin-inducible protein in rat salivary glands.
Mirels L; Hand AR; Branin HJ
J Histochem Cytochem; 1998 Sep; 46(9):1061-71. PubMed ID: 9705972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
